Author

Iris J. M. Levink

THE VALUE OF CA19.9 MONITORING IN A PANCREATIC CYST SURVEILLANCE PROGRAM: A PROSPECTIVE COHORT STUDY
THE VALUE OF CA19.9 MONITORING IN A PANCREATIC CYST SURVEILLANCE PROGRAM: A PROSPECTIVE COHORT STUDY

Iris J. M. Levink  et al.

COPY NUMBER ALTERATIONS AND GENE FUSIONS CORRELATE WITH IMMUNE CELL INFILTRATION AND SURVIVAL IN PANCREATIC CANCER
COPY NUMBER ALTERATIONS AND GENE FUSIONS CORRELATE WITH IMMUNE CELL INFILTRATION AND SURVIVAL IN PANCREATIC CANCER

Iris J. M. Levink  et al.

THE RISK OF INVASIVENESS OR DEVELOPMENT OF INDICATIONS FOR SURGERY IN PATIENTS WITH SMALL (<=20 MM) PANCREATIC NEOPLASTIC CYSTS
THE RISK OF INVASIVENESS OR DEVELOPMENT OF INDICATIONS FOR SURGERY IN PATIENTS WITH SMALL (<=20 MM) PANCREATIC NEOPLASTIC CYSTS

Iris J. M. Levink  et al.

Introduction: Best of hepatology in UEG Journal
Introduction: Best of hepatology in UEG Journal

Iris J. M. Levink  et al.

MICRORNAS OF EXTRACELLULAR VEHICLES FROM PANCREATIC JUICE AS BIOMARKERS FOR EARLY DETECTION OF PANCREATIC CANCER
MICRORNAS OF EXTRACELLULAR VEHICLES FROM PANCREATIC JUICE AS BIOMARKERS FOR EARLY DETECTION OF PANCREATIC CANCER

Iris J. M. Levink  et al.

The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program
The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program

Iris J. M. Levink  et al.

INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS IN INDIVIDUALS AT HIGH RISK OF HEREDITARY PANCREATIC CANCER: HIGHER INCIDENCE, GROWTH RATE, AND MALIGNANCY RISK
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS IN INDIVIDUALS AT HIGH RISK OF HEREDITARY PANCREATIC CANCER: HIGHER INCIDENCE, GROWTH RATE, AND MALIGNANCY RISK

Iris J. M. Levink  et al.

TIMELINE OF DEVELOPMENT OF PANCREATIC CANCER AND IMPLICATIONS FOR SUCCESSFUL EARLY DETECTION IN HIGH-RISK INDIVIDUALS
TIMELINE OF DEVELOPMENT OF PANCREATIC CANCER AND IMPLICATIONS FOR SUCCESSFUL EARLY DETECTION IN HIGH-RISK INDIVIDUALS

Iris J. M. Levink  et al.

Item 1 - 8 / 8
1